Moreover, MK2 expression is strongly upregulated in suppressive myeloid populations including both tumour-resident MDSCs and DCs and correlates with enhanced expression of known mediators of immunosuppression, such as TGF-β. This evidence concerns the gene MAPKAPK2 and neoplasm.